{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:12Z","timestamp":1786118652698,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/gme.0b013e31802cc7bc","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T05:36:07Z","timestamp":1172122567000},"page":"441-449","source":"Crossref","is-referenced-by-count":15,"title":["Provider management of menopause after the findings of the Women's Health Initiative"],"prefix":"10.1097","volume":"14","author":[{"given":"Sharon J.","family":"Rolnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kopher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terese A.","family":"Defor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210227","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"R2-20-20210227","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1146\/annurev.publhealth.26.021304.144637","article-title":"The rise and fall of menopausal hormone therapy.","volume":"26","author":"Barrett-Connor","year":"2005","journal-title":"Annu Rev Public Health"},{"key":"R3-20-20210227","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7326\/0003-4819-142-10-200505170-00011","article-title":"Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the US Preventive Services Task Force.","volume":"142","year":"2005","journal-title":"Ann Intern Med"},{"key":"R4-20-20210227","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.289.5.537","article-title":"FDA orders estrogen safety warnings: agency offers guidance for HRT use.","volume":"289","author":"Stephenson","year":"2003","journal-title":"JAMA"},{"key":"R5-20-20210227","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3949\/ccjm.68.5.441","article-title":"Coronary artery disease in women: different, often undertreated.","volume":"68","author":"Jneid","year":"2001","journal-title":"Cleve Clin J Med"},{"key":"R6-20-20210227","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1001\/archinte.160.21.3315","article-title":"Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.","volume":"160","author":"Davidson","year":"2000","journal-title":"Arch Intern Med"},{"key":"R7-20-20210227","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.GME.0000148644.55486.36","article-title":"Hormone use and patient concerns after the findings of the Women's Health Initiative.","volume":"12","author":"Rolnick","year":"2005","journal-title":"Menopause"},{"key":"R8-20-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.whi.2005.03.003","article-title":"After the Women's Health Initiative: decision making and trust of women taking hormone therapy.","volume":"15","author":"Schonberg","year":"2005","journal-title":"Womens Health Issues"},{"key":"R12-20-20210227","doi-asserted-by":"crossref","first-page":"118","DOI":"10.7326\/0003-4819-141-2-200407200-00010","article-title":"A three-part intervention to change the use of hormone replacement therapy in response to new evidence.","volume":"141","author":"Roumie","year":"2004","journal-title":"Ann Intern Med"},{"key":"R13-20-20210227","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1001\/jama.292.16.1983","article-title":"Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.","volume":"292","author":"Majumdar","year":"2004","journal-title":"JAMA"},{"key":"R14-20-20210227","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1525-1500.1998.0oa60.x","article-title":"Early- and late-stage breast cancer in a managed care setting in relation to mammography screening.","volume":"22","author":"Rolnick","year":"1998","journal-title":"Cancer Detect Prev"},{"key":"R15-20-20210227","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMsb022365","article-title":"Understanding the divergent data on postmenopausal hormone therapy.","volume":"348","author":"Grodstein","year":"2003","journal-title":"N Engl J Med"},{"key":"R16-20-20210227","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1089\/154099903322447701","article-title":"Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.","volume":"12","author":"Crandall","year":"2003","journal-title":"J Womens Health (Larchmt)"},{"key":"R17-20-20210227","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.GME.0000075503.60230.61","article-title":"Patients' and clinicians' attitudes after the Women's Health Initiative study.","volume":"11","author":"Blumel","year":"2004","journal-title":"Menopause"},{"key":"R18-20-20210227","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMp030006","article-title":"Rethinking postmenopausal hormone therapy.","volume":"348","author":"Solomon","year":"2003","journal-title":"N Engl J Med"},{"key":"R19-20-20210227","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/S0140-6736(04)17558-2","article-title":"HRT: what are women (and their doctors) to do?","volume":"364","year":"2004","journal-title":"Lancet"},{"key":"R20-20-20210227","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0378-5122(92)90003-M","article-title":"The normal menopause transition.","volume":"14","author":"McKinlay","year":"1992","journal-title":"Maturitas"},{"key":"R21-20-20210227","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.1990.tb30316.x","article-title":"Hot flashes: epidemiology and physiology.","volume":"592","author":"Kronenberg","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"R22-20-20210227","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1001\/archinte.164.21.2308","article-title":"Hormone therapy: making decisions in the face of uncertainty.","volume":"164","author":"Peterson","year":"2004","journal-title":"Arch Intern Med"},{"key":"R23-20-20210227","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1067\/S0002-9378(03)00778-6","article-title":"Decision analysis of hormone replacement therapy after the Women's Health Initiative.","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R24-20-20210227","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/107155760200900501","article-title":"The impact of the Women's Health Initiative on clinical practice.","volume":"9","author":"Speroff","year":"2002","journal-title":"J Soc Gynecol Investig"},{"key":"R25-20-20210227","first-page":"84","article-title":"Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.","volume":"8","author":"Notelovitz","year":"2006","journal-title":"MedGenMed"},{"key":"R26-20-20210227","first-page":"428","article-title":"Hormone replacement therapy: the right choice for your patient?","volume":"54","author":"Leong","year":"2005","journal-title":"J Fam Pract"},{"key":"R27-20-20210227","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.whi.2004.10.002","article-title":"Understanding physicians' attitudes towards hormone therapy.","volume":"15","author":"Hess","year":"2005","journal-title":"Womens Health Issues"},{"key":"R28-20-20210227","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1497.2006.00389.x","article-title":"Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.","volume":"21","author":"Salpeter","year":"2006","journal-title":"J Gen Intern Med"},{"key":"R29-20-20210227","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/jwh.2006.15.35","article-title":"Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.","volume":"15","author":"Grodstein","year":"2006","journal-title":"J Womens Health (Larchmt)"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-200714030-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:26:26Z","timestamp":1786033586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-200714030-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31802cc7bc","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}